Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients [Phase 2]
A Phase 2 efficacy and safety study of JTT-654 in adults with type 2 diabetes has been terminated. The update does not include trial results…
-
CLINICAL_TRIALS research · 2013-02-01Clinical Trial Update: Changes in Mitochondrial Uncoupling Protein 2 (UCP2) Messenger RNA(mRNA) in Type 2 Diabetes (T2DM) Patients
This clinical trial update reports changes in mitochondrial uncoupling protein 2 (UCP2) mRNA levels in patients with Type 2 diabetes mellitu…
-
CLINICAL_TRIALS research · 2013-01-31Clinical Trial Update: Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel
A registry study of diabetes patients in Maccabi Healthcare Services in Israel, currently enrolling by invitation.
-
FDA approval · 2013-01-30FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2013-01-30FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure [Phase 4]
A Phase 4 clinical trial assessed the effectiveness and safety of insulin glargine in patients with Type 2 diabetes mellitus after failure o…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II) [Phase 2]
A Phase 2 trial led by Aarhus University Hospital investigating diurnal variation of exogenous peptides in relation to endogenous insulin in…
-
FDA approval · 2013-01-25FDA Approved: ALOGLIPTIN — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approves the original application for alogliptin for adults with type 2 diabetes mellitus to improve glycemic control.
-
FDA approval · 2013-01-25FDA Approved: ALOGLIPTIN AND PIOGLITAZONE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a fixed-dose combination product containing alogliptin and pioglitazone from Padagis Israel Pharmaceuticals Ltd for type 2 diab…
-
FDA approval · 2013-01-25FDA Approved: KAZANO — Original Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved KAZANO, a fixed-dose combination of alogliptin and metformin hydrochloride, as a new product for managing type 2 diabetes m…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention) [Phase 3]
Phase 3 trial ORIGIN evaluated initial insulin glargine intervention in adults with type 2 diabetes mellitus; the study is completed and res…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet [Phase 1]
Phase 1 study assessing bioavailability of metformin when given as a medium-dose linagliptin/metformin combination tablet with linagliptin v…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Diet, Insulin Sensitivity And the Brain [NA]
A completed clinical trial examining how diet influences insulin sensitivity and brain function. The study involved people with obesity and …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Comprehensive Add on Study in Japan [Phase 3]
Phase 3 add-on study conducted in Japan for Type 2 diabetes has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Dose-response Study of Exendin-9,39 on Glucose Metabolism [Phase 1]
Phase 1 dose-response study evaluating the effects of Exendin-(9-39) and GLP-1(9-36) on glucose metabolism and pancreatic function; the tria…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Importance of Meal Fat Content and Gall Bladder Emptying for Postprandial GLP-1 Secretion in Type 2 Diabetes Patients
The update reports on how meal fat content and gallbladder emptying influence postprandial GLP-1 secretion in patients with Type 2 diabetes.…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Exercise Training in Type 2 Diabetes and Hypertension [Phase 4]
This update notes completion of a Phase 4 trial evaluating the effects of exercise training in people with type 2 diabetes mellitus and hype…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Common Genetic Variation and Type 2 Diabetes
Mayo Clinic-sponsored clinical trial investigating the relationship between common genetic variation and type 2 diabetes, with a focus on pr…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Diabetes Aerobic and Resistance Exercise (DARE) Study [NA]
The DARE study, evaluating aerobic and resistance exercise in individuals with Type 2 diabetes, has completed. Sponsor: Ottawa Hospital Rese…
-
CLINICAL_TRIALS research · 2013-01-18Clinical Trial Update: The Effects of Weight Loss on Neuroadrenergic Function [NA]
A clinical trial update from Baker Heart Research Institute investigating how weight loss influences neuroadrenergic function in obesity and…
-
CLINICAL_TRIALS research · 2013-01-18Clinical Trial Update: Metabolic Effects of Gastrointestinal Surgery in T2DM [NA]
This document provides an update on a clinical trial evaluating the metabolic effects of gastrointestinal surgery in people with type 2 diab…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus [NA]
A completed clinical trial assessed the combined use of colesevelam and sitagliptin in adults with type 2 diabetes and posted results in Jan…
-
CLINICAL_TRIALS research · 2013-01-15Clinical Trial Update: The Effect of Non-Surgical Periodontal Therapy on Glycemic Control and Bacterial Levels in a Mexican-American Population With Type 2 Diabetes [NA]
A completed clinical trial evaluating whether non-surgical periodontal therapy improves glycemic control and reduces bacterial levels in Mex…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion [Phase 4]
Phase 4 clinical trial update investigating how inhibiting DPP-4 affects hormonal responses to macronutrient ingestion in healthy individual…
-
CLINICAL_TRIALS withdrawal · 2013-01-15Clinical Trial Update: Customer Support Response Study
A VeraLight-sponsored clinical trial for Type 2 diabetes mellitus has been withdrawn.